Novelion Therapeutics Inc. provided net product sales guidance for the years 2016 and 2017. For the year, the company expects net product sales to be between $150 million and $152 million, exceeding high end of prior guidance.

For the year 2017, the company expects total net products sales of between $155 million and $165 million.